Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01857453 : Interest of a Dose Decrease for Radiotherapy Associated With Chemotherapy for Treatment of Standard Risk Adult Medulloblastomas
PhasePhase 2
AgesMin: 18 Years Max: 70 Years
Inclusion Criteria:

- Pathologic diagnosis of medulloblastoma expect large cells type

- Patients between 18 and 70 years

- Résidual tumor les than 1.5 square centimeter (greater diameter)

- No sus tentorial or spinal location

- Absence of tumoral cells in the cerebrospinal fluid taken before, during or 14 days
after surgery

- Absence of MYC amplification

- AID, B and C hepatitis positive serologies

- Negative ßHCG dosage and effective contraception for potentially pregnant women

- Writed consent obtain

Exclusion Criteria:

- Age < 18 or > 70 years

- Previous diagnosis of medulloblastoma

- Previous treatment with chemotherapy

- Previous cranial or spinal radiation therapy

- Carboplatinum or etoposide contraindication

- Previous cancer in the five years before the inclusion except basocellular carcinoma
of the skin and in situ cancer of the uterine cervix

- Severe renal renal insufficiency with a creatinine clearance < 60 ml/min

- Liver insufficiency with a contraindication of carboplatinum or etoposide based
chemotherapy or elevated transaminases > 3N.

- Insufficient haematopoetic reserve (thrombocytes < 100 000/mm3 ou neutrophil
polynuclear < 1500/mm3)

- Previous organ transplantation or immunosuppression

- Pregnant women or women without contraception

- Incapacity of respecting the recommanded follow up

- Participation in another therapeutic clinical trial

- Patient under custody

- Not social security regime membership
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557